Guardant Health (GH) Shares Outstanding (Weighted Average) (2017 - 2026)

Guardant Health has disclosed Shares Outstanding (Weighted Average) across 10 years of filings, most recently posting $131.3 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $131.3 million, up 5.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $131.3 million (up 5.98% YoY), and the FY2025 annual result was $125.4 million, up 2.14% from the prior year.
• Shares Outstanding (Weighted Average) came in at $131.3 million for Q1 2026 at Guardant Health, up from $125.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $131.3 million in Q1 2026 to a low of $101.9 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $121.7 million (2024), against an average of $115.7 million.
• Across the five-year window, Shares Outstanding (Weighted Average) rose 0.77% in 2022 and gained 18.55% in 2024, its largest moves.
• Guardant Health's Shares Outstanding (Weighted Average) stood at $102.2 million in 2022, then advanced by 9.6% to $112.0 million in 2023, then rose by 9.61% to $122.7 million in 2024, then increased by 2.14% to $125.4 million in 2025, then climbed by 4.71% to $131.3 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $131.3 million (Q1 2026), $125.4 million (Q4 2025), and $124.3 million (Q3 2025), per Business Quant data.